These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 2528748

  • 1. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G, Zöch G, Rath T, Meissl G.
    Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
    [No Abstract] [Full Text] [Related]

  • 2. [Thymopentin and immune response in patients with cancer].
    Petronella P, Ferrone R, Freda F, Valeriani G.
    Minerva Chir; 1989 Sep 30; 44(18):2017-20. PubMed ID: 2694011
    [Abstract] [Full Text] [Related]

  • 3. [Model for acquired immunodeficiency caused by anesthesia and surgical procedures. Effect of treatment with thymopoietin pentapeptide (TP5)].
    Auteri A, D'Aniello C, Falotico N, Saletti M, Di Perri T.
    Recenti Prog Med; 1986 Sep 30; 77(9):423-8. PubMed ID: 3541085
    [No Abstract] [Full Text] [Related]

  • 4. Influence of thymopentin on postsurgical immune deficiency: a clinical pilot study.
    Faist E, Riedel A, Bolla K.
    Int J Clin Pharmacol Res; 1987 Sep 30; 7(1):83-7. PubMed ID: 3294617
    [Abstract] [Full Text] [Related]

  • 5. A case of Di George syndrome treated with thymopoietin pentapeptide (TP-5) demonstrating an adherent suppressor cell of lymphocyte function.
    Joffe MI, Sochett E, Pettifor JM, Rabson AR.
    J Clin Lab Immunol; 1982 May 30; 8(1):69-73. PubMed ID: 6212686
    [Abstract] [Full Text] [Related]

  • 6. Thymopentin in dermatology.
    Haneke E.
    Curr Probl Dermatol; 1989 May 30; 18():283-9. PubMed ID: 2663371
    [No Abstract] [Full Text] [Related]

  • 7. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
    Garozzo G, Granà G, Lomeo E, La Greca M, Castiglione MG, Caruso M, Curatolo M, Gurgone P.
    G Ital Oncol; 1988 May 30; 8(1):11-3. PubMed ID: 3065223
    [No Abstract] [Full Text] [Related]

  • 8. Thymopentin (TP-5) therapy during lymphadenopathy syndrome (LAS/ARC): preliminary report.
    Costigliola P, Ricchi E, Colangeli V, Pintori C, Boni P, Chiodo F.
    J Exp Pathol; 1987 May 30; 3(4):705-12. PubMed ID: 3331653
    [Abstract] [Full Text] [Related]

  • 9. Thymopentin in the treatment of alopecia areata.
    Orecchia G.
    Dermatologica; 1989 May 30; 178(4):231. PubMed ID: 2670621
    [No Abstract] [Full Text] [Related]

  • 10. A prospective study of thymopentin in severely burned patients.
    Waymack JP, Jenkins M, Warden GD, Solomkin J, Law E, Hummel R, Miller A, Alexander JW.
    Surg Gynecol Obstet; 1987 May 30; 164(5):423-30. PubMed ID: 3554564
    [Abstract] [Full Text] [Related]

  • 11. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F, Businco L, Fiorilli M, Galli E, Quinti I, Le Moli S, Seminara R, Goldstein G.
    Birth Defects Orig Artic Ser; 1983 May 30; 19(3):267-72. PubMed ID: 6360238
    [No Abstract] [Full Text] [Related]

  • 12. Immunomodulation in infection caused by human immunodeficiency virus.
    Phair JP.
    J Lab Clin Med; 1989 Feb 30; 113(2):135-6. PubMed ID: 2644386
    [No Abstract] [Full Text] [Related]

  • 13. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
    Fiorilli M, Sirianni MC, Pandolfi F, Quinti I, Tosti U, Aiuti F, Goldstein G.
    Clin Exp Immunol; 1981 Aug 30; 45(2):344-51. PubMed ID: 7032772
    [Abstract] [Full Text] [Related]

  • 14. [Thymopentin in a case of autoimmune thrombocytopenia secondary to chronic lymphatic leukemia].
    Cantore M, Bucalossi A, Butini P, Carnevali A, Cavion MA, Leoncini L.
    G Clin Med; 1989 Aug 30; 70(6-7):421, 423, 425. PubMed ID: 2670653
    [Abstract] [Full Text] [Related]

  • 15. An immunomodulating drug, thymopentin, in the treatment of progressive systemic sclerosis.
    Giordano N, Biasi G, Taddeo A, Marcolongo R, Bertelletti D.
    Clin Rheumatol; 1989 Jun 30; 8(2):293-4. PubMed ID: 2667863
    [No Abstract] [Full Text] [Related]

  • 16. [A case of juvenile rheumatoid arthritis treated with thymopentin].
    Tucciarone L, Felici W, Greco L, Mechelli A.
    Minerva Pediatr; 1989 Feb 30; 41(2):109-11. PubMed ID: 2661988
    [Abstract] [Full Text] [Related]

  • 17. Immunologic effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome.
    Silvestris F, Gernone A, Frassanito MA, Dammacco F.
    J Lab Clin Med; 1989 Feb 30; 113(2):139-44. PubMed ID: 2644387
    [Abstract] [Full Text] [Related]

  • 18. Thymopentin treatment in AIDS and pre-AIDS patients.
    Clumeck N, Cran S, Van de Perre P, Mascart-Lemone F, Duchateau J, Bolla K.
    Surv Immunol Res; 1985 Feb 30; 4 Suppl 1():58-62. PubMed ID: 3898293
    [Abstract] [Full Text] [Related]

  • 19. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
    Levinsky RJ, Davies EG, Goldstein G.
    Birth Defects Orig Artic Ser; 1983 Feb 30; 19(3):273-6. PubMed ID: 6360239
    [No Abstract] [Full Text] [Related]

  • 20. [Immunologic and cytologic aspects of Hashimoto's thyroiditis during therapy with thymopentin].
    Aiello A, Cristofaro M, Carrozza F, Di Rienzo G, Carile L.
    Clin Ter; 1990 May 31; 133(4):227-31. PubMed ID: 2142910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.